{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:29:31Z","timestamp":1788866971358,"version":"build-2803163510"},"reference-count":105,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Retinoblastoma is a success story in pediatric oncology, evolving from life-saving interventions to approaches that preserve eyes and vision while minimizing complications. Initially managed with enucleation and radiotherapy, treatment now emphasizes eye preservation through chemotherapy as the cornerstone therapy. Various chemotherapy delivery methods\u2014including intravenous (IVC), intraarterial (IAC), intravitreal, intracameral, and periocular\u2014offer flexibility in treatment. Studies show nearly 100% eye salvage rates for groups A\u2013C. For advanced cases (groups D and E), IAC has achieved outcomes that were not possible before. Intravitreal injections, when performed safely, may help avoid enucleation and radiotherapy in advanced cases, preserving vision, even in complex scenarios, with vitreous seeding. Each strategy may be tailored to tumor and patient characteristics that may help optimize outcomes. Recent innovations like liquid biopsy, prenatal diagnosis, prognostic biomarkers, and new surgical methods, such as tylectomy and chemoplaque, are paving the way for more personalized care. While advanced extraocular or metastatic retinoblastoma remains challenging, these advancements underscore a shift towards better outcomes and individualized management. The future holds promise for refining treatment strategies to maximize eye and vision preservation while ensuring patient survival.<\/jats:p>","DOI":"10.3390\/medicina61071219","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T11:20:11Z","timestamp":1751628011000},"page":"1219","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Update on Retinoblastoma Therapies"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7985-5192","authenticated-orcid":false,"given":"Cristina A.","family":"Mart\u00ednez Arce","sequence":"first","affiliation":[{"name":"School of Medicine, Universidad Central del Caribe, Bayam\u00f3n 00960, Puerto Rico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor M.","family":"Villegas","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Puerto Rico, Medical Sciences Campus, San Juan 00936, Puerto Rico"},{"name":"Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Di Nicola","sequence":"additional","affiliation":[{"name":"Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Basil K.","family":"Williams","sequence":"additional","affiliation":[{"name":"Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1974-2536","authenticated-orcid":false,"given":"Timothy G.","family":"Murray","sequence":"additional","affiliation":[{"name":"Murray Ocular Oncology and Retina (MOOR), Miami, FL 33143, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13816810.2024.2449086","article-title":"Nationwide Incidence and Survival of Retinoblastoma in the USA between 1996 and 2018: A Review of 5730 Cases","volume":"46","author":"Alfaar","year":"2025","journal-title":"Ophthalmic Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/bjo.2008.138750","article-title":"Incidence of Retinoblastoma in the USA: 1975\u20132004","volume":"93","author":"Broaddus","year":"2009","journal-title":"Br. J. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ophtha.2003.10.023","article-title":"Incidence of Retinoblastoma from 1958 to 1998 in Northern Europe: Advantages of Birth Cohort Analysis","volume":"111","author":"Seregard","year":"2004","journal-title":"Ophthalmology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"103810","DOI":"10.1016\/j.jaapos.2023.11.013","article-title":"The Association between Race and Age of Diagnosis of Reti-noblastoma in United States Children","volume":"28","author":"Black","year":"2024","journal-title":"J. Am. Assoc. Pediatr. Ophthalmol. Strabismus"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1001\/jamapediatrics.2015.2360","article-title":"Ethnic, Racial, and Socioeconomic Disparities in Retinoblastoma","volume":"169","author":"Truong","year":"2015","journal-title":"JAMA Pediatr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ajo.2023.11.004","article-title":"Retinoblastoma Outcomes in the Americas: A Prospective Analysis of 491 Children with Retinoblastoma from 23 American Countries","volume":"260","author":"Berry","year":"2024","journal-title":"Am. J. Ophthalmol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e1128","DOI":"10.1016\/S2214-109X(22)00250-9","article-title":"The Global Retinoblastoma Outcome Study: A Prospective, Cluster-Based Analysis of 4064 Patients from 149 Countries","volume":"10","author":"Fabian","year":"2022","journal-title":"Lancet Glob. Health"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e1279","DOI":"10.1002\/cnr2.1279","article-title":"Reasons for Missed Chemotherapy Appointments in Retinoblastoma Patients Undergoing Chemotherapy: A Report from a Tertiary Care Hospital from India","volume":"3","author":"Gupta","year":"2020","journal-title":"Cancer Rep."},{"key":"ref_9","unstructured":"Benedicto, N. (2020). Factors Associated with Refusal for Enucleation Among Parents\/Caregivers of Children with Retinoblastoma at Muhimbili National Hospital. [Master\u2019s Thesis, Muhimbili University of Health and Allied Sciences]."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4103\/2347-5625.207736","article-title":"Psychosocial Factors Influencing Parental Decision to Allow or Refuse Potentially Lifesaving Enucleation in Children with Retinoblastoma","volume":"4","author":"Domingo","year":"2017","journal-title":"Asia Pac. J. Oncol. Nurs."},{"key":"ref_11","unstructured":"Villegas, V., Gold, A., Wildner, A., Thomson, J., Ehlies, F., and Murray, T. (2015). Personalized Medicine in Ocular Oncology, Retina Today."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"pgac162","DOI":"10.1093\/pnasnexus\/pgac162","article-title":"Second Hit Impels Oncogenesis of Retinoblastoma in Patient-Induced Pluripotent Stem Cell-Derived Retinal Organoids: Direct Evidence for Knudson\u2019s Theory","volume":"1","author":"Li","year":"2022","journal-title":"PNAS Nexus"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/APO.0000000000000219","article-title":"Genetics of Retinoblastoma","volume":"5","author":"Mallipatna","year":"2016","journal-title":"Asia-Pac. J. Ophthalmol."},{"key":"ref_14","first-page":"4371","article-title":"Retinoblastoma: From Discovery to Clinical Management","volume":"289","author":"Rangel","year":"2021","journal-title":"FEBS J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/ceo.12277","article-title":"Genomic Landscape of Retinoblastoma","volume":"42","author":"Villegas","year":"2014","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ophtha.2017.09.001","article-title":"Screening Children at Risk for Retinoblastoma: Consensus Report from the American Association of Ophthalmic Oncologists and Pathologists","volume":"125","author":"Skalet","year":"2018","journal-title":"Ophthalmology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/ICU.0000000000000002","article-title":"Retinoblastoma","volume":"24","author":"Villegas","year":"2013","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1080\/13816810.2019.1681010","article-title":"Aseptic Pediatric Orbital Cellulitis: Retinoblastoma until Otherwise Proven","volume":"40","author":"Pinto","year":"2019","journal-title":"Ophthalmic Genet."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ehlers, J. (2020). Retinoblastoma. The Retina Illustrated, Thieme.","DOI":"10.1055\/b-0040-174185"},{"key":"ref_20","first-page":"11","article-title":"Classification and Staging of Retinoblastoma","volume":"31","author":"Fabian","year":"2018","journal-title":"Community Eye Health"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ohc.2004.11.003","article-title":"Intraocular Retinoblastoma: The Case for a New Group Classification","volume":"18","year":"2005","journal-title":"Ophthalmol. Clin. N. Am."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/pbc.20606","article-title":"A Proposal for an International Retinoblastoma Staging System","volume":"47","author":"Chantada","year":"2006","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.ophtha.2020.05.050","article-title":"A Multicenter, International Collaborative Study for American Joint Committee on Cancer Staging of Retinoblastoma: Part I: Metastasis-Associated Mortality","volume":"127","author":"Tomar","year":"2020","journal-title":"Ophthalmology"},{"key":"ref_24","first-page":"10","article-title":"Managing Retinoblastoma in 2025","volume":"36","author":"Williams","year":"2025","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/archophthalmol.2011.5","article-title":"Intra-Arterial Chemotherapy for the Management of Retinoblastoma Four-Year Experience","volume":"129","author":"Gobin","year":"2011","journal-title":"Arch. Ophthalmol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Zhao, J., Feng, Z., Leung, G., and Gallie, B.L. (2021). Retinoblastoma Survival Following Primary Enucleation by Ajcc Staging. Cancers, 13.","DOI":"10.3390\/cancers13246240"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/bjo-2023-324746","article-title":"Retinoblastoma Survival and Enu-cleation Outcomes in 41 Countries from the African Continent","volume":"109","author":"Nishath","year":"2025","journal-title":"Br. J. Ophthalmol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2147\/OPTH.S398488","article-title":"Effectiveness of Intra-Arterial Chemotherapy for the Treatment of Intraocular Retinoblastoma: Relevance of a Multi-disciplinary Setting","volume":"17","author":"Castela","year":"2023","journal-title":"Clin. Ophthalmol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"\u00d6zdek, \u015e., Berrocal, A., and Spandau, U. (2023). Treatment Modalities and Enucleation. Pediatric Vitreoretinal Surgery, Springer International Publishing.","DOI":"10.1007\/978-3-031-14506-3"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/aorn.12896","article-title":"An Overview of Retinoblastoma and Enucleation in Pediatric Patients","volume":"111","author":"Leclerc","year":"2020","journal-title":"AORN J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1080\/01676830.2018.1440605","article-title":"Porous Orbital Implant after Enucleation in Retinoblastoma Patients: Indications and Complications","volume":"37","author":"Lang","year":"2018","journal-title":"Orbit"},{"key":"ref_32","first-page":"20","article-title":"How to Do an Enucleation for Retinoblastoma","volume":"31","author":"Kaliki","year":"2018","journal-title":"Community Eye Health J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3349\/ymj.2015.56.6.1478","article-title":"Treatment of Retinoblastoma: The Role of External Beam Radiotherapy","volume":"56","author":"Kim","year":"2015","journal-title":"Yonsei Med. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4103\/ojo.OJO_250_2019","article-title":"Prognostic Factors for Eye Globe Salvage by External Beam Radiation Therapy for Resistant Intraocular Retinoblastoma","volume":"13","author":"Yousef","year":"2020","journal-title":"Oman J. Ophthalmol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2147\/CMAR.S351744","article-title":"Technological Advancements in External Beam Radiation Therapy (EBRT): An Indispensable Tool for Cancer Treatment","volume":"14","author":"Koka","year":"2022","journal-title":"Cancer Manag. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ijrobp.2014.07.031","article-title":"Proton Radiation Therapy for the Treatment of Retinoblastoma","volume":"90","author":"Mouw","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"490","DOI":"10.14338\/IJPT-15-00016.1","article-title":"The Evolution of Radiation Therapy for Retinoblastoma: The MD Anderson Cancer Center Experience","volume":"2","author":"Agarwal","year":"2016","journal-title":"Int. J. Part. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/S0161-6420(01)00797-7","article-title":"Plaque Radiotherapy for Retinoblastoma Long-Term Tumor Control and Treatment Complications in 208 Tumors","volume":"108","author":"Shields","year":"2001","journal-title":"Ophthalmol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Schaiquevich, P., Francis, J.H., Cancela, M.B., Carcaboso, A.M., Chantada, G.L., and Abramson, D.H. (2022). Treatment of Retinoblastoma: What Is the Latest and What Is the Future. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.822330"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/ICU.0000000000000091","article-title":"Targeted Retinoblastoma Management: When to Use Intravenous, Intra-Arterial, Periocular, and Intravitreal Chemotherapy","volume":"25","author":"Shields","year":"2014","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"100061","DOI":"10.1016\/j.apjo.2024.100061","article-title":"Update on Chemotherapy Modalities for Retinoblastoma: Progress and Challenges","volume":"13","author":"Kritfuangfoo","year":"2024","journal-title":"Asia-Pac. J. Ophthalmol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1001\/jama.2024.19981","article-title":"Three vs. 6 Cycles of Chem-otherapy for High-Risk Retinoblastoma: A Randomized Clinical Trial","volume":"332","author":"Ye","year":"2024","journal-title":"JAMA"},{"key":"ref_43","first-page":"1548","article-title":"Long-Term (20-Year) Real-World Outcomes of Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 964 Eyes of 554 Patients at a Single Centre","volume":"104","author":"Shields","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4143\/crt.2021.1537","article-title":"The Efficacy of Alternate Systemic Intravenous Chemotherapy and Intra-Arterial Chemotherapy Approach for Eye Globe Salvage in Retinoblastoma","volume":"55","author":"Han","year":"2023","journal-title":"Cancer Res. Treat."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archophthalmol.2011.150","article-title":"Intra-Arterial Chemotherapy for Retinoblastoma: Report No. 1, Control of Retinal Tumors, Subretinal Seeds, and Vitreous Seeds","volume":"129","author":"Shields","year":"2011","journal-title":"Arch. Ophthalmol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/APO.0000000000000172","article-title":"Unilateral Retinoblastoma Managed With Intravenous Chemotherapy Versus Intra-Arterial Chemotherapy. Outcomes Based on the International Classification of Retinoblastoma","volume":"5","author":"Shields","year":"2016","journal-title":"Asia-Pac. J. Ophthalmol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s40135-023-00311-0","article-title":"Intra-Arterial Chemotherapy for Retinoblastoma","volume":"11","author":"Muns","year":"2023","journal-title":"Curr. Ophthalmol. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaophthalmol.2023.4825","article-title":"Incidence and Risk Factors for Neutropenia after Intra-Arterial Chemotherapy for Retinoblastoma","volume":"141","author":"Lee","year":"2023","journal-title":"JAMA Ophthalmol."},{"key":"ref_49","first-page":"251","article-title":"Atypical Event Profiling of Intra-Arterial Chemotherapy","volume":"6","author":"Bach","year":"2022","journal-title":"J. Vitr. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1136\/neurintsurg-2019-014909","article-title":"Intra-Arterial Chemotherapy for Retinoblastoma: An Updated Systematic Review and Meta-Analysis","volume":"11","author":"Ravindran","year":"2019","journal-title":"J. Neurointerv. Surg."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/IAE.0000000000001382","article-title":"Rhegmatogenous Retinal Detachment After Intraarterial Chemotherapy for Retinoblastoma: The 2016 Founders Award Lecture","volume":"37","author":"Shields","year":"2017","journal-title":"Retina"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/bjophthalmol-2019-315209","article-title":"Histopathology of Retinoblastoma Eyes Enucleated after Intra-Arterial Chemotherapy","volume":"104","author":"Biewald","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/jamaophthalmol.2016.0244","article-title":"Intra-Arterial Chemotherapy for Retinoblastoma: A Systematic Review","volume":"134","author":"Yousef","year":"2016","journal-title":"JAMA Ophthalmol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4103\/0974-9233.65492","article-title":"Spontaneously Resolving Periocular Erythema and Ciliary Madarosis Following Intra-Arterial Chemotherapy for Retinoblastoma","volume":"17","author":"Marr","year":"2010","journal-title":"Middle East Afr. J. Ophthalmol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/13816810.2014.973045","article-title":"Classification and Management of Seeds in Retinoblastomaellsworth Lecture Ghent August 24th 2013","volume":"35","author":"Munier","year":"2014","journal-title":"Ophthalmic Genet."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archophthalmol.2012.1983","article-title":"Intravitreal Melphalan for Refractory or Recurrent Vitreous Seeding From Retinoblastoma","volume":"130","author":"Ghassemi","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"ref_57","first-page":"119","article-title":"Efficacy of Intravitreal Injections of Melphalan in the Treatment of Reti-noblastoma Vitreous Seeding","volume":"33","author":"Rogowska","year":"2024","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/jamaophthalmol.2014.414","article-title":"Combined Intravitreal Melphalan and Topotecan for Refractory or Recurrent Vitreous Seeding from Retinoblastoma","volume":"132","author":"Ghassemi","year":"2014","journal-title":"JAMA Ophthalmol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/bjophthalmol-2020-318529","article-title":"Evaluation of Intravitreal Topotecan Dose Levels, Toxicity and Efficacy for Retinoblastoma Vitreous Seeds: A Preclinical and Clinical Study","volume":"106","author":"Bogan","year":"2022","journal-title":"Br. J. Ophthalmol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/eye.2012.175","article-title":"Retinoblas-toma Frontiers with Intravenous, Intra-Arterial, Periocular, and Intravitreal Chemotherapy","volume":"27","author":"Shields","year":"2013","journal-title":"Eye"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/archophthalmol.2011.130","article-title":"Periocular Topotecan for Intraocular Retinoblastoma","volume":"129","author":"Mallipatna","year":"2011","journal-title":"Arch. Ophthalmol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.4103\/ijo.IJO_737_18","article-title":"Periocular Topotecan for Vitreous Seeds in Retinoblastoma","volume":"66","author":"Sthapit","year":"2018","journal-title":"Indian J. Ophthalmol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/archopht.121.8.1120","article-title":"Ocular Motility Changes After Sub-tenon Carboplatin Chemotherapy for Retinoblastoma","volume":"121","author":"Mulvihill","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/cncr.25574","article-title":"Sub-conjunctival Carboplatin and Systemic Topotecan Treatment in Preclinical Models of Retinoblastoma","volume":"117","author":"Nemeth","year":"2011","journal-title":"Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.ophtha.2008.07.003","article-title":"Clinical Spectrum of Diffuse Infiltrating Retinoblastoma in 34 Consecutive Eyes","volume":"115","author":"Shields","year":"2008","journal-title":"Ophthalmology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.sjopt.2013.06.006","article-title":"Diffuse Anterior Retinoblastoma: A Review","volume":"27","author":"Jijelava","year":"2013","journal-title":"Saudi J. Ophthalmol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/ceo.13964","article-title":"Aqueous Seeding in Intraocular Retinoblastoma: A Review","volume":"49","author":"Kaliki","year":"2021","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000453617","article-title":"Intracameral Chemotherapy (Melphalan) for Aqueous Seeding in Retinoblastoma: Bicameral Injection Technique and Related Toxicity in a Pilot Case Study","volume":"3","author":"Munier","year":"2016","journal-title":"Ocul. Oncol. Pathol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/bjo-2022-322492","article-title":"Ten-Year Experience with Intracameral Chemotherapy for Aqueous Seeding in Retinoblastoma: Long-Term Efficacy, Safety and Toxicity","volume":"108","author":"Stathopoulos","year":"2024","journal-title":"Br. J. Ophthalmol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"218","DOI":"10.22336\/rjo.2021.44","article-title":"Less Is More: New One-Step Intracameral Chemotherapy Technique","volume":"65","author":"Borroni","year":"2021","journal-title":"Rom. J. Ophthalmol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Zhao, J., Li, Q., Feng, Z.X., Zhang, J., Wu, S., Jin, L., and Gallie, B.L. (2021). Tylectomy Safety in Salvage of Eyes with Retinoblastoma. Cancers, 13.","DOI":"10.3390\/cancers13225862"},{"key":"ref_72","unstructured":"Gallie, B. (2024). Topotecan Episcleral Plaque for Treatment of Retinoblastoma (STEP-RB)-Identifier NCT04428879, National Library of Medicine."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2147\/IJGM.S380634","article-title":"Prenatal Diagnosis of Retinoblastomas: A Scoping Review","volume":"16","author":"Rodriguez","year":"2023","journal-title":"Int. J. Gen. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3928\/01913913-20240425-01","article-title":"Microflow Imaging of Fetal Retinoblastoma","volume":"61","author":"Lewis","year":"2024","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/IAE.0000000000000861","article-title":"Optic Nerve Infiltration by Retinoblastoma: Predictive Clinical Features and Outcome","volume":"36","author":"Kaliki","year":"2016","journal-title":"Retina"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Zugbi, S., Ganiewich, D., Bhattacharyya, A., Aschero, R., Ottaviani, D., Sampor, C., Cafferata, E.G., Mena, M., Sgroi, M., and Winter, U. (2020). Clinical, Genomic, and Pharmacological Study of MYCN-Amplified RB1 Wild-Type Metastatic Retinoblastoma. Cancers, 12.","DOI":"10.3390\/cancers12092714"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"155392","DOI":"10.1016\/j.prp.2024.155392","article-title":"ALYREF\/THOC4 Expression and Cell Growth Modulation in Retinoblastoma","volume":"260","author":"Seigel","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"ref_78","first-page":"250","article-title":"Identification of MiR-20a as a Potential Discerning Biomarker for Non-Invasive versus Invasive Retinoblastoma","volume":"26","author":"Bereimipour","year":"2024","journal-title":"Cell J."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/08820538.2022.2078165","article-title":"Liquid Biopsy in Retinoblastoma: A Review","volume":"37","author":"Ghose","year":"2022","journal-title":"Semin. Ophthalmol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Chigane, D., Pandya, D., Singh, M., Brown, B., Lin, M., Xu, L., Stacey, A.W., Bonnell, A.C., Hubbard, G.B., and Grossniklaus, H. (Ophthalmology, 2025). Safety Assessment of Aqueous Humor Liquid Biopsy in Retinoblastoma, Ophthalmology, online ahead of print.","DOI":"10.1016\/j.ophtha.2025.03.018"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ajo.2023.11.020","article-title":"Aqueous Humor Liquid Biopsy as a Companion Diagnostic for Retinoblastoma: Implications for Diagnosis, Prognosis, and Therapeutic Options: Five Years of Progress","volume":"263","author":"Berry","year":"2024","journal-title":"Am. J. Ophthalmol."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Abramson, D.H., Mandelker, D.L., Brannon, A.R., Dunkel, I.J., Benayed, R., Berger, M.F., Arcila, M.E., Ladanyi, M., Friedman, D.N., and Jayakumaran, G. (2023). Mutant-RB1 Circulating Tumor DNA in the Blood of Unilateral Retinoblastoma Patients: What Happens during Enucleation Surgery: A Pilot Study. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0271505"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1158\/0008-5472.CAN-18-1127","article-title":"Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer","volume":"79","author":"Anagnostou","year":"2016","journal-title":"Cancer Res."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Daniels, A.B., Patel, S.N., Milam, R.W., Kohanim, S., Friedman, D.L., and Koyama, T. (2021). Effect of Intravenous Chemotherapy Regimen on Globe Salvage Success Rates for Retinoblastoma Based on Disease Class\u2014A Meta-Analysis. Cancers, 13.","DOI":"10.3390\/cancers13092216"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/13816810.2024.2388579","article-title":"What Have We Learned about Intraarterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Retinoblastoma in the Past 18 Years? The Third A. Linn Murphree Lecture","volume":"45","author":"Abramson","year":"2024","journal-title":"Ophthalmic Genet."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000491580","article-title":"Primary Intra-Arterial Chemotherapy for Retinoblastoma in the Intravitreal Chemotherapy Era: Five Years of Experience","volume":"5","author":"Dalvin","year":"2019","journal-title":"Ocul. Oncol. Pathol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1177\/1120672120957587","article-title":"Secondary Intra-Arterial Chem-otherapy and\/or Intravitreal Chemotherapy as Salvage Treatment for Retinoblastoma","volume":"31","author":"Mirzayev","year":"2021","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Zhao, J., Feng, Z., and Gallie, B.L. (2021). Natural History of Untreated Retinoblastoma. Cancers, 13.","DOI":"10.3390\/cancers13153646"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ophtha.2022.04.022","article-title":"Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study","volume":"129","author":"Tomar","year":"2022","journal-title":"Ophthalmology"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/archopht.126.6.862","article-title":"The Adverse Events of Chemotherapy for Retinoblastoma What Are They? Do We Know?","volume":"126","author":"Rizzuti","year":"2008","journal-title":"Arch. Ophthalmol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/bmt.2011.108","article-title":"Successful Treatment of Metastatic Retinoblastoma with High-Dose Chemotherapy and Autologous Stem Cell Rescue in South America","volume":"47","author":"Palma","year":"2012","journal-title":"Bone Marrow Transpl."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1158\/1078-0432.CCR-24-0221","article-title":"Targeting GPC2 on Intraocular and CNS Metastatic Retinoblastomas with Local and Systemic Delivery of CAR T Cells","volume":"30","author":"McIntyre","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Larrosa, C., Simao-Rafael, M., Salvador, N., Mu\u00f1oz, J.P., Lavarino, C., Chantada, G., and Mora, J. (2025). Case Report: Successful Treat-ment of Metastatic Retinoblastoma with CNS Involvement with Anti-GD2 Immunotherapy, Intrathecal Topotecan and Re-duced Systemic Chemotherapy. Front. Pediatr., 12.","DOI":"10.3389\/fped.2024.1509645"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00262-023-03587-0","article-title":"Targeted Therapies in Retinoblastoma: GD2-Directed Immunotherapy Following Autologous Stem Cell Transplantation and Evaluation of Alternative Target B7-H3","volume":"73","author":"Eichholz","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2147\/OPTH.S195145","article-title":"Prevalence of Refractive Errors in Children with Retinoblastoma","volume":"13","author":"Villegas","year":"2019","journal-title":"Clin. Ophthalmol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.jaapos.2016.07.178","article-title":"Prevalence of Refractive Errors in Pediatric Patients with Retinoblastoma","volume":"20","author":"Villegas","year":"2016","journal-title":"J. Am. Assoc. Pediatr. Ophthalmol. Strabismus"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Masoomian, B., Shields, C.L., Esfahani, H.R., Khalili, A., Ghassemi, F., Rishi, P., Akbari, M.R., and Khorrami-Nejad, M. (2024). Strabismus Management in Retinoblastoma Survivors. BMC Ophthalmol., 24.","DOI":"10.1186\/s12886-024-03379-9"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1158\/1078-0432.CCR-17-0652","article-title":"Retinoblastoma and Neuroblastoma Predisposition and Surveillance","volume":"23","author":"Kamihara","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10555-014-9544-y","article-title":"Retinoblastoma: Might Photodynamic Therapy Be an Option?","volume":"34","author":"Teixo","year":"2015","journal-title":"Cancer Metastasis Rev."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Walther, J., Schastak, S., Dukic-Stefanovic, S., Wiedemann, P., Neuhaus, J., and Claudepierre, T. (2014). Efficient Photodynamic Therapy on Human Retinoblastoma Cell Lines. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0087453"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e2202219","DOI":"10.1002\/adhm.202202219","article-title":"Highly Efficient Photodynamic Therapy with Mitochondria-Targeting Aggregation-Induced Emission Photosensitizer for Retinoblastoma","volume":"12","author":"Zhou","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Mandal, M., Banerjee, I., and Mandal, M. (2022). Nanoparticle-Mediated Gene Therapy as a Novel Strategy for the Treatment of Retinoblastoma. Colloids Surf. B Biointerfaces, 220.","DOI":"10.1016\/j.colsurfb.2022.112899"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"9321","DOI":"10.1126\/scitranslmed.aat9321","article-title":"Therapeutic Targeting of the RB1 Pathway in Retinoblastoma with the Oncolytic Adenovirus VCN-01","volume":"11","author":"Olaciregui","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/1878-0261.13587","article-title":"New Retinoblastoma (RB) Drug Delivery Approaches: Anti-Tumor Effect of Atrial Natriuretic Peptide (ANP)-Conjugated Hyaluronic-Acid-Coated Gold Nanoparticles for Intraocular Treatment of Chemoresistant RB","volume":"18","author":"Haase","year":"2024","journal-title":"Mol. Oncol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.ophtha.2020.05.024","article-title":"Recommendations for Long-Term Follow-up of Adults with Heritable Retinoblastoma","volume":"127","author":"Tonorezos","year":"2020","journal-title":"Ophthalmology"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1219\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:04:30Z","timestamp":1760033070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":105,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["medicina61071219"],"URL":"https:\/\/doi.org\/10.3390\/medicina61071219","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]}}}